MASI Learn · Program design
Stacks and multi-month longevity programs
The practical answer: the best MASI stack is the smallest program that matches a clear goal, fits your medicines and health context, and can be followed consistently for 90 days. NMN is the usual core for NAD+ precursor support; resveratrol, spermidine, or fisetin add different research lanes. Combining them does not turn supplements into treatment or guarantee a larger effect.
Choose the program before choosing the number of bottles
Start with the outcome you can act on: cellular-energy support, a polyphenol-focused program, autophagy biology, senescence research, or hair nutrition. Then select one core product and decide whether a second product contributes a genuinely different role. This keeps the program understandable and makes adverse effects or adherence problems easier to identify.
| Goal | MASI starting point | Optional addition |
|---|---|---|
| NAD+ precursor support | NMN | Resveratrol for a separate polyphenol lane |
| Polyphenol program | Resveratrol | NMN if NAD+ support is also a priority |
| Autophagy-focused program | Spermidine | NMN as a separate cellular-energy layer |
| Senescence research interest | Fisetin | Keep expectations tied to limited human outcome evidence |
| Hair nutrition | Premium Hair Complex | Add longevity molecules only for separate goals |
What each product contributes
NMN: a precursor used by the NAD+ salvage pathway. Human trials show oral bioactivity and changes in NAD-related biomarkers, while functional outcomes vary. Human dose-ranging trial. Read NMN and NAD+ biology.
Resveratrol: a polyphenol studied in vascular, metabolic, inflammatory, and stress-response contexts. Human findings are population- and endpoint-specific. A 24-month crossover trial in postmenopausal women reported cognitive, cerebrovascular, and cardiometabolic outcomes but does not establish universal benefit. Read the trial.
Spermidine: a naturally occurring polyamine linked mechanistically to autophagy. Human cognitive trials have not established it as a dementia treatment. Read the randomized trial. See spermidine biology and use.
Fisetin: a flavonoid studied extensively in cell and animal models of senescence. Human outcome evidence remains early, so the defensible program is research-informed use rather than a claim to clear senescent cells in a customer. See fisetin evidence and use.
A practical 90-day build
- Weeks 1–2: choose one core product, follow its label, and keep exercise, sleep, and diet stable enough to interpret tolerability.
- Weeks 3–4: review adherence, digestion, sleep, medication timing, and any new symptoms. Stop and seek advice for a concerning reaction.
- Weeks 5–12: if the core is well tolerated and a second pathway matches the goal, add one product—not several at once.
- Day 90: assess whether the program is practical, affordable, and aligned with useful outcomes such as training consistency, sleep routine, or hair-photo tracking. Biomarkers should be interpreted with a clinician.
Consolidating a 90-day supply can simplify adherence, but only after the combination has been reviewed and tolerated. More products increase cost and interaction complexity; they do not automatically improve results.
How to read stack evidence
Most human trials test one intervention, not the exact MASI combination. Mechanistic complementarity can explain why products belong in different lanes, but it cannot prove synergy. Human, animal, and cellular findings should therefore remain separate. When a study reports a biomarker change, do not translate it into disease prevention without direct evidence.
Safety and medicine review
Review the exact stack with a clinician or pharmacist if you use anticoagulants, antiplatelet drugs, diabetes medicines, blood-pressure medicines, immunosuppressants, or cancer treatment. Pregnancy, nursing, liver or kidney disease, upcoming surgery, and unexplained symptoms also warrant individual advice. Keep prescription treatment unchanged unless the prescriber directs otherwise.
Frequently asked questions
What is the simplest MASI longevity stack?
For many adults, the simplest program is NMN alone as an NAD+ precursor, paired with exercise, sleep, and nutrition. Add resveratrol, spermidine, or fisetin only when its separate pathway matches the goal and the medicine review is clear.
Should I take every product at the same time?
No. Follow each label and introduce products sequentially. Timing should support adherence and tolerability rather than a claim of proven synergy. If a product affects your stomach or sleep, separating doses can help identify the cause, but persistent symptoms require review.
Does a 90-day program prove that a supplement works?
No. Ninety days is an adherence and tolerability framework, not a clinical trial. It helps determine whether the routine is sustainable and whether useful lifestyle measures remain on track. Disease risk and laboratory markers need appropriate clinical interpretation.
Can MASI stacks replace prescription treatment?
No. MASI supplements are nutritional and longevity-program products, not substitutes for diabetes, cardiovascular, neurological, or weight-management medicines. Continue prescribed care and ask the prescriber to review the exact ingredients when combining them.
Compare all MASI Learn pathways and view each product’s label before building your program.